EUROLAB
usp-1010-analytical-data-integrity-in-impurity-reporting
Impurity Profiling EMA Guideline on Genotoxic Impurities in PharmaceuticalsEMA Reflection Paper on Low Level ImpuritiesFDA Guidance: Microbial Impurities and Endotoxin LevelsFDA Guidance: Threshold of Toxicological Concern (TTC) for ImpuritiesFDA ICH M3(R2): Impurities in Safety StudiesFDA Q&A on Impurities in Generic Drug ApplicationsFDA Q&A: Managing Impurities in Complex APIsICH E14: QT Interval Evaluation and Impurity ImpactICH M7: Mutagenic Impurity Risk AssessmentICH Q10: Pharmaceutical Quality System for Impurity ManagementICH Q11: Impurity Control Strategy in Drug Substance DevelopmentICH Q12: Lifecycle Management of Impurity Control StrategyICH Q1E: Evaluation of Stability Data Related to Impurity FormationICH Q2(R1): Validation of Analytical Methods for Impurity TestingICH Q3A: Organic Impurity Profiling in Drug SubstancesICH Q3B: Impurity Testing in Finished Drug ProductsICH Q3C: Residual Solvent ProfilingICH Q3D: Elemental Impurity Risk AssessmentICH Q3F: Impurity Guidelines for Biotechnology ProductsICH Q4B: Harmonization of Analytical Procedures for Impurity TestingICH Q5C: Impurity Monitoring in Biotechnological ProductsICH Q6A: Specifications and Acceptance Criteria for ImpuritiesICH S3A: Impurities Arising from Degradation ProductsICH S6: Biotech Product Impurity ProfilingICH S7A: Safety Pharmacology Impurity EvaluationICH S9: Impurities in Oncology ProductsISO 10993-18: Chemical Characterization and Impurity AnalysisISO 17025: Accreditation for Impurity Testing LaboratoriesJP General Rule 2.60: Limit Test for ImpuritiesPh. Eur. 2.2.28: Gas Chromatography for Impurity DetectionPh. Eur. 2.2.38: Thin-Layer Chromatography for ImpuritiesPh. Eur. 2.2.46: Chromatographic Separation for Impurity AnalysisPh. Eur. 2.4.14: Determination of Inorganic ImpuritiesPh. Eur. 2.4.20: Limit Test for Heavy Metals in ImpuritiesPh. Eur. 2.4.24: Related Substances by HPLC in APIsPh. Eur. 2.4.29: Limit Test for Sulfated Ash ImpuritiesPh. Eur. 2.5.13: Oxidizing Impurity TestsPh. Eur. 2.9.40: Uniformity of Dosage Units and Related ImpuritiesPh. Eur. 5.10: Control of Impurities in Substances for Pharmaceutical UsePh. Eur. 5.4: Impurities in Radiopharmaceutical PreparationsUSP <1031>: The Biocompatibility of Materials and ImpuritiesUSP <1051>: Cleaning Validation Limits and Residual ImpuritiesUSP <1058>: Analytical Instrument Qualification for Impurity StudiesUSP <1078>: Good Manufacturing Practices for Impurity ReductionUSP <1085>: Evaluation of Impurity Method PerformanceUSP <1086>: Impurities in Drug SubstancesUSP <1088>: Forced Degradation Studies for Impurity CharacterizationUSP <1091>: Impurity Isolation and Characterization TechniquesUSP <1099>: Acceptable Analytical Performance CriteriaUSP <1121>: Bulk Pharmaceutical Chemicals and Impurity HandlingUSP <1151>: Pharmaceutical Dosage Forms and Impurity ConsiderationUSP <1191>: Stability Testing of Compounded PreparationsUSP <1222>: Terminal Sterilization Impact on ImpuritiesUSP <1224>: Transfer of Impurity Test ProceduresUSP <1225>: Validation of Compendial Procedures for ImpuritiesUSP <1226>: Verification of Compendial Procedures for Impurity DetectionUSP <1231>: Water for Pharmaceutical Purposes and Impurity EffectsUSP <1232>: Water Activity and Impurity StabilityUSP <1241>: Capsules and Shell Impurity InteractionUSP <1251>: Weighing on Analytical Balances for Micro-ImpuritiesUSP <161>: Transdermal Delivery Systems and Impurity ControlUSP <197>: Spectrophotometric Identification of ImpuritiesUSP <233>: Elemental Impurities Profiling Using ICP-MSUSP <41>: Balances Used for Impurity Weight DeterminationUSP <466>: Identification and Quantification of DegradantsUSP <467>: Residual Solvent Testing in APIs and ExcipientsUSP <476>: Impurity Profiling for New Drug ApplicationsUSP <621>: Chromatography Conditions for Impurity IdentificationUSP <730>: Plasma Spectrochemistry for Impurity ProfilingUSP <791>: pH Determination Impact on Impurity SolubilityUSP <797>: Sterile Compounding and Impurity ControlUSP <800>: Hazardous Drug Handling Based on Impurity RiskUSP <851>: Spectrophotometry and Light Scattering for ImpuritiesUSP <853>: Atomic Absorption Spectroscopy for Trace ImpuritiesUSP <857>: UV-Vis Spectroscopy for Impurity QuantificationUSP <85>: Bacterial Endotoxin Limits Related to Impurity SafetyUSP <891>: Nuclear Magnetic Resonance (NMR) for Structural ElucidationUSP <905>: Content Uniformity Related to ImpuritiesUSP <905>: Uniformity of Dosage Units Affected by ImpuritiesUSP <941>: Characterization of Impurity Solubility and pKaWHO TRS 970 Annex 2: Impurity Control in Medicines

Complete Guide to USP <1010>: Analytical Data Integrity in Impurity Reporting Testing Services by Eurolab

USP <1010> is a comprehensive standard that governs the analytical data integrity of impurity reporting in pharmaceutical testing. This standard is developed and published by the United States Pharmacopeia (USP), a non-profit organization that sets standards for quality, purity, and identity of pharmaceutical ingredients.

Legal and Regulatory Framework

The USP <1010> standard is based on the International Conference on Harmonisation (ICH) guidelines, which provide a framework for regulatory authorities to ensure the safety, efficacy, and quality of pharmaceutical products. The ICH guidelines are adopted by regulatory agencies worldwide, including the US FDA, EMA, and others.

International and National Standards

The following standards apply to USP <1010>:

  • ISO 17025:2017 General requirements for the competence of testing and calibration laboratories

  • ASTM E2500-17 Standard guide for establishment of computerized systems for laboratory quality control data (R2020)

  • EN ISO/IEC 17065:2012 Conformity assessment -- Requirements for bodies certifying products, processes, and services

    • Standard Development Organizations

    The USP is a member of the International Council for Harmonisation (ICH), which is responsible for developing global guidelines for pharmaceutical testing. Other standard development organizations that contribute to USP <1010> include:

  • American Society for Testing and Materials (ASTM)

  • International Organization for Standardization (ISO)

  • European Committee for Standardization (CEN)

    • Evolution of Standards

    Standards evolve through a collaborative effort between industry stakeholders, regulatory agencies, and standard development organizations. New standards are developed in response to emerging technologies, changing regulations, or industry needs.

    Standard Numbers and Scope

    The following standard numbers apply to USP <1010>:

  • USP <1010>: Analytical Data Integrity in Impurity Reporting

  • ISO 17025:2017 General requirements for the competence of testing and calibration laboratories

  • ASTM E2500-17 Standard guide for establishment of computerized systems for laboratory quality control data (R2020)

    • Standard Compliance Requirements

    Compliance with USP <1010> is required by various industries, including:

  • Pharmaceutical manufacturers

  • Contract research organizations (CROs)

  • Clinical research sites

  • Food and beverage manufacturers

    • Non-compliance can result in regulatory actions, product recalls, or even business closure.

    Business and Technical Reasons for Conducting USP <1010> Testing

    USP <1010> testing is necessary to ensure the accuracy, reliability, and integrity of analytical data. This standard helps laboratories meet regulatory requirements and industry standards by:

  • Ensuring accurate results

  • Preventing errors and anomalies

  • Maintaining documentation and record-keeping

  • Protecting intellectual property rights

    • Consequences of non-compliance can include financial losses, reputation damage, or even business closure.

    Industries and Sectors Requiring USP <1010> Testing

    The following industries require USP <1010> testing:

  • Pharmaceutical manufacturers

  • Biotechnology companies

  • Food and beverage manufacturers

  • Cosmetics and personal care products

    • These industries rely on accurate analytical data to ensure product safety, efficacy, and quality.

    Risk Factors and Safety Implications

    Non-compliance with USP <1010> can result in:

  • Patient harm or death due to inaccurate results

  • Product recalls and financial losses

  • Regulatory actions and business closure

    • This standard helps mitigate these risks by ensuring accurate analytical data.

    Quality Assurance and Quality Control Aspects

    USP <1010> emphasizes the importance of quality assurance and quality control measures, including:

  • Equipment calibration and maintenance

  • Operator training and qualification

  • Document control and record-keeping

  • Internal audits and assessments

    • These measures ensure that analytical data is accurate, reliable, and trustworthy.

    Contributions to Product Safety and Reliability

    USP <1010> contributes to product safety and reliability by ensuring:

  • Accurate results

  • Reliable documentation

  • Preventing errors and anomalies

    • This standard helps manufacturers maintain public trust and confidence in their products.

    Competitive Advantages of Having USP <1010> Testing Performed

    Companies that comply with USP <1010> enjoy:

  • Enhanced reputation and credibility

  • Increased customer trust and confidence

  • Improved regulatory compliance

  • Cost savings through reduced errors and anomalies

    • Non-compliance can result in loss of market share, revenue decline, or even business closure.

    Cost-Benefit Analysis of Performing USP <1010> Testing

    Performing USP <1010> testing can:

  • Reduce costs associated with product recalls and regulatory actions

  • Increase revenue through enhanced reputation and customer trust

  • Improve productivity through reduced errors and anomalies

    • This standard helps laboratories maximize their return on investment (ROI) while minimizing risks.

    Technical Requirements for Conducting USP <1010> Testing

    To conduct USP <1010> testing, laboratories must:

  • Meet ISO 17025:2017 general requirements for the competence of testing and calibration laboratories

  • Implement ASTM E2500-17 standard guide for establishment of computerized systems for laboratory quality control data (R2020)

  • Maintain accurate documentation and record-keeping

    • These technical requirements ensure that analytical data is accurate, reliable, and trustworthy.

    Conclusion

    USP <1010> is a comprehensive standard that governs the analytical data integrity of impurity reporting in pharmaceutical testing. Compliance with this standard ensures:

  • Accurate results

  • Reliable documentation

  • Preventing errors and anomalies

    • Non-compliance can result in regulatory actions, product recalls, or even business closure.

    By understanding the requirements and benefits of USP <1010>, laboratories can ensure their analytical data meets industry standards and regulatory requirements.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    CONTACT US +902127020000

    Latest News

    View all

    Eurolab Successfully Renews ISO 17025 Accreditation

    Read More

    Expanded Cosmetic Safety Testing Portfolio Now Available at Eurolab

    Read More

    Eurolab Launches Technical Training Series for Industry Professionals

    Read More

    JOIN US
    Want to make a difference?

    Careers